A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01883011
Recruitment Status : Terminated (This study was terminated after a pre-specified interim analysis. Please see Detailed Study Description for further information.)
First Posted : June 21, 2013
Last Update Posted : August 30, 2013
Information provided by (Responsible Party):
UCB Pharma ( UCB S.A. - Pharma Sector )

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2001
  Study Completion Date : July 2001